Skip to main content

Table 5 Loss of productivity among patients and their caregivers*

From: Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study

Variable description

90 days before enrolment (N = 637)

From enrolment to follow-up examination 1 (N = 614)

From follow-up examination 1 to 2 (N = 603)

From follow-up examination 2 to 3 (N = 587)

Frequency of idle patients

52.8%

51.3%

50.8%

49.3%

Frequency of patients losing ≥1 day of productivity

23.3%

8.5%

7.3%

9.4%

Frequency of caregivers losing ≥1 day of productivity

18.6%

8.7%

11.0%

11.0%

No. days/patient-month of productivity loss (computed among the whole study sample)

2.9 (0.0-30.0)

1.0 (0.0-30.0)

0.6 (0.0-30.0)

0.6 (0.0-30.0)

No. days/patient-month of productivity loss (computed among patients loosing productivity)

12.6 (0.3-30.0)

12.0 (0.3-30.0)

8.4 (0.3-30.0)

6.2 (0.4-30.0)

No. days/caregiver-month of productivity loss (computed among all caregivers in the study sample)

1.2 (0.0-30.0)

0.2 (0.0-7.5)

0.5 (0.0-28.1)

0.2 (0–5.4)

No. days/caregiver-month of productivity loss (computed among caregivers loosing productivity)

6.3 (1.0-30.0)

2.8 (0.3-7.5)

4.1 (0.6-28.1)

1.5 (0.4-30.0)

No. days/patient-month of total productivity loss by both patients and caregivers (computed among patients study sample)

3.5 (0.0-60.0)

1.1 (0.0-31.7)

0.8 (0.0-33.7)

0.7 (0.0-30.0)

  1. * values for days/person-month are mean values (min-max).